drugset / Trial / NCT02170064
Pharmacokinetics, Efficacy and Tolerability of BIA 2-093
Parallel-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the pharmacokinetics of Eslicarbazepine acetate in children and adolescents with epilepsy.
Timeline
- Start
- 2005-06
- Primary completion
- 2006-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 30 mg/kg | Oral |